4 - NOMURA HOLDINGS INC (0001163653) (Issuer)
Live Feed
Delayed 3mInsider · FDA · Large Ownership Changes
Signed out · 3-min delay · Sign up for real-time
- Officer Kato Sotaro covered exercise/tax liability with 22,483 shares, converted options into 78,036 shares and returned $293,393 worth of shares to the company (35,736 units at $8.21), increasing direct ownership by 46% to 62,774 units (SEC Form 4) (for withholding tax)
- SEC Form 4 filed by Director Liang Jianzhang
4 - Trip.com Group Ltd (0001269238) (Issuer)
- Director Ogawa Shoji was granted 221 shares (SEC Form 4)
4 - NOMURA HOLDINGS INC (0001163653) (Issuer)
- CEO Wang Xueji disposed of 383 units of Class B Common Stock and acquired 383 shares (SEC Form 4)
4 - Tuya Inc. (0001829118) (Issuer)
- President Chen Liaohan disposed of 237 units of Class B Common Stock and acquired 237 shares (SEC Form 4)
4 - Tuya Inc. (0001829118) (Issuer)
- Director Chen Jeffrey sold $4,257,000 worth of Ordinary Shares (9,000 units at $473.00) (SEC Form 4)
4 - ASE Technology Holding Co., Ltd. (0001122411) (Issuer)
- President, R&D Plump Andrew Stewart was granted 212,470 units of American Depositary Shares, increasing direct ownership by 36% to 806,572 units (SEC Form 4)
4 - TAKEDA PHARMACEUTICAL CO LTD (0001395064) (Issuer)
- Head, Strat. & Port. Dev. Pignagnoli Agosti Marcello was granted 27,740 units of American Depositary Shares, increasing direct ownership by 19% to 172,348 units (SEC Form 4)
4 - TAKEDA PHARMACEUTICAL CO LTD (0001395064) (Issuer)
- Chief Transformation Officer Duprey Lauren Rusckowski was granted 59,990 units of American Depositary Shares, increasing direct ownership by 36% to 228,503 units (SEC Form 4)
4 - TAKEDA PHARMACEUTICAL CO LTD (0001395064) (Issuer)
- CEO - Elect Kim Julie So-Young was granted 105,416 units of American Depositary Shares, increasing direct ownership by 32% to 430,145 units (SEC Form 4)
4 - TAKEDA PHARMACEUTICAL CO LTD (0001395064) (Issuer)
- Chief Data & Tech. Officer Ricci Gabriele was granted 34,994 units of American Depositary Shares, increasing direct ownership by 28% to 159,126 units (SEC Form 4)
4 - TAKEDA PHARMACEUTICAL CO LTD (0001395064) (Issuer)
- Chief Financial Officer Furuta Milano was granted 7,800 units of Ordinary Shares, increasing direct ownership by 16% to 57,900 units (SEC Form 4) (withholding obligation)
4 - TAKEDA PHARMACEUTICAL CO LTD (0001395064) (Issuer)